City

Clinical trials near Suzhou, China

Active studies with a listed research site in Suzhou, China.

12active studies

6recruiting now

9countries represented

138largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Urinary Incontinence,StressCondition

Orforglipron, PlaceboTreatment

Canada, China136 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT07202884See eligibility →

Recruiting nowPhase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, China80 locations

Novo Nordisk A/SSponsor

Updated 2026-07-13 · NCT07571005See eligibility →

Recruiting nowNot applicable

Time Restricted Eating in Childhood Obesity (TRECO)

Childhood ObesityCondition

Calorie-restricted diet (CRD), Time-restricted eating (TRE)Treatment

China2 locations

Xiaoyan ShiSponsor

Updated 2026-05-08 · NCT06583447See eligibility →

Recruiting nowNot applicable

ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

Obesity, Weight ControlCondition

Mazdutide, Intensive Lifestyle InterventionTreatment

China13 locations

Shanghai Zhongshan HospitalSponsor

Updated 2026-04-08 · NCT07517042See eligibility →

Recruiting nowPhase 1

Bioequivalence Study of GZR18 Injection Before and After CMC Change

Obesity&T2DCondition

GZR18 injection A, GZR18 injection BTreatment

China1 locations

Gan & Lee Pharmaceuticals.Sponsor

Updated 2026-01-22 · NCT07355738See eligibility →

Recruiting nowNot applicable

Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children

Childhood Obesity, Childhood Obesity PeventionCondition

12-hour time-restricted eating, health educationTreatment

China2 locations

Children's Hospital of Soochow UniversitySponsor

Updated 2025-09-30 · NCT07184281See eligibility →

Opening soonPhase 2, Phase 3

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

Acute Ischemic Stroke (AIS)Condition

Tirzepatide, Standard Medical Care (SMC)Treatment

China1 locations

yifang zhuSponsor

Updated 2026-07-29 · NCT07734792See eligibility →

Opening soonPhase 3

A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）

Overweight or ObesityCondition

MDR-001, PlaceboTreatment

China45 locations

MindRank AI LtdSponsor

Updated 2025-12-22 · NCT07274137See eligibility →

Opening soonPhase 3

A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

ObesityCondition

Semaglutide, SemaglutideTreatment

China14 locations

Hangzhou Jiuyuan Gene Engineering Co. Ltd.,Sponsor

Updated 2024-10-09 · NCT06633783See eligibility →

Active, not recruitingPhase 3

A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Obesity, OverweightCondition

Orforglipron, PlaceboTreatment

Brazil, China138 locations

Eli Lilly and CompanySponsor

Updated 2026-08-14 · NCT05869903See eligibility →

Active, not recruitingNot applicable

A Multifaceted Intervention to Reduce Obesity Among Preschool Children: Study Protocol for a Randomized Controlled Trial in Suzhou City

Children, Obesity & OverweightCondition

Student-focused activities, Activities towards parents (providing a supportive family environment)Treatment

China1 locations

Soochow UniversitySponsor

Updated 2026-07-27 · NCT07361211See eligibility →

Active, not recruitingPhase 2, Phase 3

The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)

Obesity and OverweightCondition

Phase IIb：Efsubaglutide Alfa 5 mg QW, Phase IIb：Efsubaglutide Alfa 10 mg QWTreatment

China41 locations

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.Sponsor

Updated 2026-01-30 · NCT06921486See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Suzhou, China

Current studies

Related cities